Key result
The release of the 2017 ACC/AHA hypertension guidelines was associated with a significant reduction in average systolic blood pressure by 2.41 mmHg and an increase in prescribed antihypertensive medications.
Why the study?
Following the 2017 ACC/AHA reclassification of hypertension with lower diagnostic thresholds, the impact on hypertension management in real-world clinical practice was explored.
Does the 2017 ACC/AHA hypertension guideline reclassification increase the number of antihypertensive medications prescribed and reduce blood pressure in patients at a single cardiology practice?
Observational (n=441)
No
Does the 2017 ACC/AHA hypertension guideline reclassification increase the number of antihypertensive medications prescribed and reduce blood pressure in patients at a single cardiology practice?
The 2017 ACC/AHA hypertension guideline reclassification was associated with a significant increase in antihypertensive medications prescribed and a decrease in systolic blood pressure in a real-world cardiology practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Naqvi et al. (2022) conducted an observational in Essential Hypertension (n=441). 2017 ACC/AHA Hypertension Guidelines vs. Pre-guideline period (12 months prior) was evaluated on Systolic blood pressure (MD -2.41, 95% CI 1.18-3.63, p=<0.0001). The release of the 2017 ACC/AHA hypertension guidelines was associated with a significant reduction in average systolic blood pressure by 2.41 mmHg and an increase in prescribed antihypertensive medications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: